Literature DB >> 4827070

Biochemical basis of malignant hyperpyrexia.

R F Moulds, M A Denborough.   

Abstract

Pharmacologically-induced muscle contracture in vitro has been used as a model to study the biochemical basis of malignant hyperpyrexia. In 15 susceptible subjects halothane, succinylcholine, and potassium chloride all produced an abnormal muscle contracture, and the caffeine-induced contracture was greater than normal. The contractures were reproducible only in the presence of extracellular calcium ions. The fact that such dissimilar pharmacological stimuli all induced contracture in the affected muscle suggests that the essential abnormality in the muscle cell in malignant hyperpyrexia is an impaired binding of calcium ions to the membranes of the sarcoplasmic reticulum and the sarcolemma. Exposure of these membranes to halothane, succinylcholine, and other anaesthetic agents then leads to a rapid and abnormally large release of calcium into the myoplasm, which in turn gives rise to all the clinical features of the syndrome.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4827070      PMCID: PMC1610509          DOI: 10.1136/bmj.2.5913.241

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  Anaesthetic deaths in a family.

Authors:  M A DENBOROUGH; J F FORSTER; R R LOVELL; P A MAPLESTONE; J D VILLIERS
Journal:  Br J Anaesth       Date:  1962-06       Impact factor: 9.166

2.  Activation of the contractile mechanism in striated muscle.

Authors:  J AXELSSON; S THESLEFF
Journal:  Acta Physiol Scand       Date:  1958-10-28

Review 3.  Molecular control mechanisms in muscle contraction.

Authors:  A Weber; J M Murray
Journal:  Physiol Rev       Date:  1973-07       Impact factor: 37.312

4.  Pharmacological action of local anesthetics on excitation-contraction coupling in striated and smooth muscle.

Authors:  M B Feinstein; M Paimre
Journal:  Fed Proc       Date:  1969 Sep-Oct

5.  Metabolic error of muscle metabolism after recovery from malignant hyperthermia.

Authors:  W Kalow; B A Britt; M E Terreau; C Haist
Journal:  Lancet       Date:  1970-10-31       Impact factor: 79.321

6.  An in-vitro model of anesthetic hypertonic hyperpyrexia, halothane--caffeine-induced muscle contractures: prevention of contracture by procainamide.

Authors:  G E Strobel; C P Bianchi
Journal:  Anesthesiology       Date:  1971-11       Impact factor: 7.892

7.  The action of caffeine on the activation of the contractile mechanism in straited muscle fibres.

Authors:  H C Lüttgau; H Oetliker
Journal:  J Physiol       Date:  1968-01       Impact factor: 5.182

8.  Malignant hyperpyrexia. Further muscle studies in asymptomatic carriers identified by creatinine phosphokinase screening.

Authors:  H Isaacs; M B Barlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-04       Impact factor: 10.154

9.  Procaine in malignant hyperpyrexia.

Authors:  R F Moulds; M A Denborough
Journal:  Br Med J       Date:  1972-12-02

10.  The mechanism of the action of caffeine on sarcoplasmic reticulum.

Authors:  A Weber
Journal:  J Gen Physiol       Date:  1968-11       Impact factor: 4.086

View more
  23 in total

1.  Malignant hyperthermia and althesin.

Authors:  N Honda; K Konno; Y Itohda; M Nishino; S Matsushima; S Haseba; Y Honda; Y Gotoh
Journal:  Can Anaesth Soc J       Date:  1977-07

2.  Atypical malignant hyperthermia with persistent hyperkalaemia during renal transplantation.

Authors:  M L Simons; E Goldman
Journal:  Can J Anaesth       Date:  1988-07       Impact factor: 5.063

Review 3.  Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum.

Authors:  P J O'Brien
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

4.  Letter: Myopathies and malignant hyperpyrexia.

Authors:  R F Moulds; M A Denborough
Journal:  Br Med J       Date:  1974-08-24

5.  Identification of susceptibility to malignant hyperpyrexia.

Authors:  R F Moulds; M A Denborough
Journal:  Br Med J       Date:  1974-05-04

6.  Is malignant hyperpyrexia muscle denervated?

Authors:  R F Moulds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-10       Impact factor: 10.154

7.  Malignant hyperthermia: a disease of specific myofiber type?

Authors:  T E Nelson; S S Schochet
Journal:  Can Anaesth Soc J       Date:  1982-03

8.  Perfusion of malignant hyperthermia susceptible and normal isolated pig livers with halothane.

Authors:  B A Britt; B Shandling; L Endrenyl; G M Kent
Journal:  Can Anaesth Soc J       Date:  1978-09

9.  A comparison of the effects of sodium thiocyanate and dantrolene sodium on a mammalian isolated skeletal muscle.

Authors:  R F Moulds
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

10.  [A case of malignant hyperthermia occuring in a dental clinic].

Authors:  A Martel; L Spigelblatt; L Perreault; R Rosenfeld
Journal:  Can Anaesth Soc J       Date:  1979-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.